Abstract Background/aims: Some studies showed that probiotics could improve the composition and structure of gut microbiota. Changes in the gut…
Abstract Cannabis-derived therapies are gaining popularity in the medical world. More and more perfect forms of cannabinoids are sought, which…
Abstract In the current review, we focused on identifying aliment compounds and micronutrients, as well as addressed promising bioactive nutrients…
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease; however, no specific pharmacological therapy…
Abstract Obesity and nonalcoholic fatty liver disease (NAFLD) constitute global and growing epidemics that result in therapeutic dead ends. There…
Abstract Bile acid (BA) synthesis from cholesterol by hepatocytes is inhibited by inflammatory cytokines. Whether liver inflammation also affects BA…
Abstract Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral hepatitis are the main causes of morbidity and…
Abstract Background: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome, which often includes obesity, diabetes, and dyslipidemia. Several…
Abstract Non-alcoholic fatty liver disease (NAFLD) is increasingly encountered. It is associated with several comorbid diseases. However, its association with…
Abstract Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in adults in developed countries, with a…